Femasys (FEMY) Share-based Compensation (2020 - 2026)
Femasys' (FEMY) quarterly Share-based Compensation came in at $151608.0 in Q1 2026, down 58.72% YoY from $367237.0 in Q1 2025, and up 128.25% on a QoQ basis from $66423.0 in Q4 2025.
Femasys (FEMY) Share-based Compensation (2020 - 2026) Analysis & Trends
Femasys (FEMY) has 7 years of Share-based Compensation data on file, last reported at $151608.0 in Q1 2026.
- Quarterly Share-based Compensation fell 58.72% year-over-year to $151608.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $719411.0 (down 1.96% YoY) and the FY2025 annual result came in at $983577.0, down 25.02% from the prior year.
- Share-based Compensation advanced to $151608.0 in Q1 2026, from $66423.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $1.9 million in Q4 2023 to a low of $44359.0 in Q1 2022.
- A 5-year average of $433585.2 and a median of $128406.0 in 2024 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2024 — Share-based Compensation slumped 92.83% — and 2025, when it soared 1600.56%.
- Tracing FEMY's Share-based Compensation over 5 years: stood at $224939.0 in 2022, then soared by 731.53% to $1.9 million in 2023, then slumped by 92.83% to $134143.0 in 2024, then sank by 50.48% to $66423.0 in 2025, then soared by 128.25% to $151608.0 in 2026.
- The last three Share-based Compensation figures came in at $151608.0 (Q1 2026), $66423.0 (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 67.10 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 55.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 42.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 27.46 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 29.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 38.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 33.00 Mn |
| 10 | Femasys | 8.98 Mn | 7.54 Mn | 189,391.00 | 210,820.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 151,608.00 |
| Mar 31, 2026 | 151,608.00 |
| Dec 31, 2025 | 66,423.00 |
| Dec 31, 2025 | 66,423.00 |
| Sep 30, 2025 | 1.69 Mn |
| Sep 30, 2025 | 1.69 Mn |
| Jun 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | 1.77 Mn |
| Mar 31, 2025 | 367,237.00 |
| Mar 31, 2025 | 367,237.00 |
| Dec 31, 2024 | 134,143.00 |
| Dec 31, 2024 | 134,143.00 |
| Sep 30, 2024 | 128,406.00 |
| Sep 30, 2024 | 128,406.00 |
| Jun 30, 2024 | 104,013.00 |
| Jun 30, 2024 | 104,013.00 |
| Mar 31, 2024 | 77,585.00 |
| Mar 31, 2024 | 77,585.00 |
| Dec 31, 2023 | 1.87 Mn |
| Dec 31, 2023 | 1.87 Mn |